Class information for:
Level 1: IMMUNE BASED THERAPY//AIDS MED ONCOL//CLIN MOL RETROVIROL SECT

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
28171 212 36.2 87%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
7 4 INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY 1353914
29 3       HIV//VIROLOGY//HIV 1 108954
10 2             AIDS RESEARCH AND HUMAN RETROVIRUSES//VIROLOGY//HIV 1 39664
28171 1                   IMMUNE BASED THERAPY//AIDS MED ONCOL//CLIN MOL RETROVIROL SECT 212

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 IMMUNE BASED THERAPY authKW 376337 4% 29% 9
2 AIDS MED ONCOL address 288070 1% 100% 2
3 CLIN MOL RETROVIROL SECT address 259248 4% 20% 9
4 ALDESLEUKIN authKW 162036 1% 38% 3
5 75 MIU PROLEUKIN authKW 144035 0% 100% 1
6 ADULT AIDS CLIN TRIALS UNIT address 144035 0% 100% 1
7 AIDS CLIN TRIALS UNITROOM S156 address 144035 0% 100% 1
8 AIDS IMMUNO PATHOGENESIS UNIT address 144035 0% 100% 1
9 ANIM MODELS RETROCIRAL VACCINES SECT address 144035 0% 100% 1
10 AUSTIN COOPERAT PROGRAM address 144035 0% 100% 1

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Infectious Diseases 6389 51% 0% 109
2 Immunology 3722 63% 0% 133
3 Virology 1925 23% 0% 49
4 Microbiology 309 17% 0% 36
5 Pharmacology & Pharmacy 80 14% 0% 29
6 Medicine, Research & Experimental 25 5% 0% 11
7 Medicine, General & Internal 24 7% 0% 14
8 Medical Ethics 11 0% 0% 1
9 Hematology 9 3% 0% 6
10 Ethics 3 0% 0% 1

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 AIDS MED ONCOL 288070 1% 100% 2
2 CLIN MOL RETROVIROL SECT 259248 4% 20% 9
3 ADULT AIDS CLIN TRIALS UNIT 144035 0% 100% 1
4 AIDS CLIN TRIALS UNITROOM S156 144035 0% 100% 1
5 AIDS IMMUNO PATHOGENESIS UNIT 144035 0% 100% 1
6 ANIM MODELS RETROCIRAL VACCINES SECT 144035 0% 100% 1
7 AUSTIN COOPERAT PROGRAM 144035 0% 100% 1
8 BIRMINGHAM INFECT DIS 144035 0% 100% 1
9 COORDINAT BIOMET 144035 0% 100% 1
10 CPCRA STAT DATA MANAGEMENT 144035 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 AIDS 18250 16% 0% 33
2 JOURNAL OF INFECTIOUS DISEASES 3950 10% 0% 22
3 JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 2961 3% 0% 6
4 AIDS RESEARCH AND HUMAN RETROVIRUSES 2684 5% 0% 10
5 HIV CLINICAL TRIALS 2521 1% 1% 3
6 CLINICAL IMMUNOLOGY 1933 3% 0% 6
7 PLOS CLINICAL TRIALS 1869 0% 1% 1
8 HIV MEDICINE 1182 1% 0% 3
9 JOURNAL OF INTERFERON AND CYTOKINE RESEARCH 1019 2% 0% 4
10 JOURNAL OF CLINICAL IMMUNOLOGY 909 2% 0% 4

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 IMMUNE BASED THERAPY 376337 4% 29% 9 Search IMMUNE+BASED+THERAPY Search IMMUNE+BASED+THERAPY
2 ALDESLEUKIN 162036 1% 38% 3 Search ALDESLEUKIN Search ALDESLEUKIN
3 75 MIU PROLEUKIN 144035 0% 100% 1 Search 75+MIU+PROLEUKIN Search 75+MIU+PROLEUKIN
4 CD4 CELL COUNT RESPONSES 144035 0% 100% 1 Search CD4+CELL+COUNT+RESPONSES Search CD4+CELL+COUNT+RESPONSES
5 CD8 CELL ANTI HIV ACTIVITY 144035 0% 100% 1 Search CD8+CELL+ANTI+HIV+ACTIVITY Search CD8+CELL+ANTI+HIV+ACTIVITY
6 CD8 CELL NUMBER 144035 0% 100% 1 Search CD8+CELL+NUMBER Search CD8+CELL+NUMBER
7 CLINICAL ENDPOINT STUDY 144035 0% 100% 1 Search CLINICAL+ENDPOINT+STUDY Search CLINICAL+ENDPOINT+STUDY
8 CONTINUED FOLLOW UP 144035 0% 100% 1 Search CONTINUED+FOLLOW+UP Search CONTINUED+FOLLOW+UP
9 DISCORDANT IMMUNE RESPONSE 144035 0% 100% 1 Search DISCORDANT+IMMUNE+RESPONSE Search DISCORDANT+IMMUNE+RESPONSE
10 EARLY STAGE HIV INFECTION 144035 0% 100% 1 Search EARLY+STAGE+HIV+INFECTION Search EARLY+STAGE+HIV+INFECTION

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 MARCHETTI, G , TINCATI, C , MONFORTE, AD , GORI, A , (2008) THE CHALLENGE OF IL-2 IMMUNOTHERAPY IN HIV DISEASE: "NO THROUGH ROAD" OR TURNING POINT?.CURRENT HIV RESEARCH. VOL. 6. ISSUE 3. P. 189-199 46 77% 7
2 DURIER, C , CAPITANT, C , LASCAUX, AS , GOUIARD, C , OKSENHENDLER, E , POIZOT-MARTIN, I , VIARD, JP , WEISS, L , NETZER, E , DELFRAISSY, JF , ET AL (2007) LONG-TERM EFFECTS OF INTERMITTENT INTERLEUKIN-2 THERAPY IN CHRONIC HIV-INFECTED PATIENTS (ANRS 048-079 TRIALS).AIDS. VOL. 21. ISSUE 14. P. 1887 -1897 31 89% 21
3 ABRAMS, D , LEVY, Y , LOSSO, MH , BABILKER, A , COLLINS, G , COOPER, DA , DARBYSHIRE, J , EMERY, S , FOX, L , GORDIN, F , ET AL (2009) INTERLEUKIN-2 THERAPY IN PATIENTS WITH HIV INFECTION.NEW ENGLAND JOURNAL OF MEDICINE. VOL. 361. ISSUE 16. P. 1548-1559 18 78% 208
4 PETT, SL , KELLEHER, AD , EMERY, S , (2010) ROLE OF INTERLEUKIN-2 IN PATIENTS WITH HIV INFECTION.DRUGS. VOL. 70. ISSUE 9. P. 1115-1130 39 46% 11
5 TEMESGEN, Z , (2006) INTERLEUKIN-2 FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION.DRUGS OF TODAY. VOL. 42. ISSUE 12. P. 791 -801 32 53% 3
6 FOX, Z , ANTUNES, F , DAVEY, R , GAZZARD, B , KLIMAS, N , LABRIOLA, A , LOSSO, M , NEATON, JD , PHILLIPS, AN , RUXRUNGTHAM, K , ET AL (2007) PREDICTORS OF CD4 COUNT CHANGE OVER 8 MONTHS OF FOLLOW UP IN HIV-1-INFECTED PATIENTS WITH A CD4 COUNT >= 300 CELLS/MU L WHO WERE ASSIGNED TO 7.5 MIU INTERLEUKIN-2.HIV MEDICINE. VOL. 8. ISSUE 2. P. 112-123 19 86% 0
7 VIARD, JP , FAGARD, C , CHAIX, ML , ROUZIOUX, C , BOUTELOUP, V , BENTATA, M , DE VERDIERE, NC , PAHLAVAN, G , WEISS, L , LEVY, Y , ET AL (2009) IMMUNOLOGICAL SUCCESS IS PREDICTED BY ENFUVIRTIDE BUT NOT INTERLEUKIN-2 THERAPY IN IMMUNODEPRESSED PATIENTS.AIDS. VOL. 23. ISSUE 11. P. 1383-1388 19 79% 3
8 DE BOER, AW , MARKOWITZ, N , LANE, HC , SARAVOLATZ, LD , KOLETAR, SL , DONABEDIAN, H , YOSHIZAWA, C , DULIEGE, AM , FYFE, G , MITSUYASU, RT , (2003) A RANDOMIZED CONTROLLED TRIAL EVALUATING THE EFFICACY AND SAFETY OF INTERMITTENT 3-, 4-, AND 5-DAY CYCLES OF INTRAVENOUS RECOMBINANT HUMAN INTERLEUKIN-2 COMBINED WITH ANTIRETROVIRAL THERAPY (ART) VERSUS ART ALONE IN HIV-SEROPOSITIVE PATIENTS WITH 100-300 CD4(+) T CELLS.CLINICAL IMMUNOLOGY. VOL. 106. ISSUE 3. P. 188-196 22 79% 16
9 ANAYA, JR , SIAS, JJ , (2005) THE USE OF INTERLEUKIN-2 IN HUMAN IMMUNODEFICIENCY VIRUS INFECTION.PHARMACOTHERAPY. VOL. 25. ISSUE 1. P. 86-95 23 68% 4
10 MARKOWITZ, N , LOPARDO, G , WENTWORTH, D , GEY, D , BABIKER, A , FOX, L , TAVEL, J , (2012) LONG-TERM EFFECTS OF INTERMITTENT IL-2 IN HIV INFECTION: EXTENDED FOLLOW-UP OF THE INSIGHT STALWART STUDY.PLOS ONE. VOL. 7. ISSUE 10. P. - 17 74% 5

Classes with closest relation at Level 1


Rank Class id link
1 9126 NAIVE AND MEMORY CD4 T CELLS//SECC INMUNOPEDIAT//BIOSISTEMA 1
2 21102 ANTI CD3 CD28 COATED BEADS//CD8 CELL ANTIVIRAL ACTIVITY//CD8 CELL ANTIVIRAL RESPONSES
3 12458 MICROBIAL TRANSLOCATION//IMMUNE ACTIVATION//HUMAN IMMUNOL SECT
4 3643 HIV LATENCY//HIV RESERVOIR//HIV CURE
5 2716 ANTIRETROVIRAL THERAPY//ROYAL FREE HIV MED//CD4 CELL COUNT
6 7823 INTERLEUKIN 7//IL 7//INTERLEUKIN 7 RECEPTOR
7 8329 ANTI IFN ALPHA IMMUNIZATION//EQUIPE INTERFERON CYTOKINES//ANTI CYTOKINE VACCINATION
8 1456 PARTNERS AIDS//DORIS DUKE MED//HIV PATHOGENESIS PROGRAMME
9 10888 IMMUNE RECONSTITUTION//TREC//LYMPHOCYTE RECOVERY
10 1471 INTERLEUKIN 2//LYMPHOKINE ACTIVATED KILLER CELLS//RECOMBINANT INTERLEUKIN 2

Go to start page